reports
- MarketLine Department
Prinova Group LLC - Company Profile and SWOT Analysis
Summary Prinova Group LLC - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Prinova Group LLC (Prinova) manufactures and distributes ingredient and flavor solutions. The company's product portfolio includes acidulants, antioxidants, amino acids, botanical extracts, colors, es...
- MarketLine Department
Disproquima SA - Strategy, SWOT and Corporate Finance Report
Summary Disproquima SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Disproquima SA (Disproquima) is a marketer and distributor of wide range of functional ingredients. The company’s product portfolio includes active pharmaceutical ingredients, vitamins and mine...
Adicet Bio Inc: 2 directors
A director at Adicet Bio Inc bought 5,000 shares at 2.400USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
ACETO Completes the Sale of Its Chemicals Business Assets
ACETO Completes the Sale of Its Chemicals Business Assets PORT WASHINGTON, N.Y., April 30, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management. The purchase price paid in the transaction consisted of cash plus the payment of cure costs and the assumption of certain liabilities. ACETO used a portion of the proceeds from the transaction to repay 100% of ...
ACETO to Sell its Chemicals Business Assets to New Mountain Capital
ACETO to Sell its Chemicals Business Assets to New Mountain Capital PORT WASHINGTON, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has agreed to sell its chemicals business assets to an affiliate of New Mountain Capital (“NMC”), a leading growth-oriented investment firm with over $20 billion in assets under management. The asset purchase agreement was entered into following ...
ACETO Receives Court Approval of “Stalking Horse†Agreement to Sel...
ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. PORT WASHINGTON, N.Y., April 12, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plu...
ACETO Enters into “Stalking Horse†Agreement to Sell Rising Pharma...
ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals PORT WASHINGTON, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with Shore Suven Pharma, Inc. to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries for gross cash proceeds of $15 million, plus the assumption of operating li...
ACETO Announces Receipt of Nasdaq Notice Due to Delay in Filing Form 1...
ACETO Announces Receipt of Nasdaq Notice Due to Delay in Filing Form 10-Q for the Fiscal Quarter Ended December 31, 2018 PORT WASHINGTON, N.Y., Feb. 20, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it received a notification from the Nasdaq Stock Market (“Nasdaq”) on February 13, 2019 informing Aceto that since Aceto had not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
ACETO Announces Proposed Sale of its Chemicals Business Assets to New ...
ACETO Announces Proposed Sale of its Chemicals Business Assets to New Mountain Capital for $338 million ACETO and its U.S. Subsidiaries File Voluntary Chapter 11 Petitions to Facilitate SaleSecures Commitment for Debtor-in-Possession Financing to Support Normal Course OperationsACETO Pursuing Court-Supervised Sale of Rising Pharmaceuticals PORT WASHINGTON, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chem...
ACETO Reports Fiscal 2019 First Quarter Results
ACETO Reports Fiscal 2019 First Quarter Results PORT WASHINGTON, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fiscal 2019 first quarter ended September 30, 2018. First Quarter Fiscal 2019 versus First Quarter Fiscal 2018 Net sales of $164.4 million versus $185.3 million Gross profit of $25.5 million versus $40 millionNet loss of $(21.1) mi...
ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net...
ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits PORT WASHINGTON, N.Y., Nov. 05, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) today announced that its Board of Directors has adopted a tax asset protection rights plan (the “Rights Plan”). The Rights Plan is designed to preserve ACETO’s net operating loss carryforwards (NOLs) and other significant tax benefits which may be available to reduce potential future tax liabilities. ACETO’s Board determined that the Rights Plan was warranted and in the best int...
ACETO Corporation Schedules First Quarter & Fiscal 2019 Financial Resu...
ACETO Corporation Schedules First Quarter & Fiscal 2019 Financial Results News Release and Conference Call PORT WASHINGTON, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the first quarter of fiscal 2019 ended September 30, 2018 after the stock market close on Thursday, November 8, 2018. Management will host a conference call to discuss the operati...
ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results
ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results Performance Chemicals and Pharmaceutical Ingredients Continue Strong Performance Repaid $43.2 Million of Debt During Fiscal Year 2018 PORT WASHINGTON, N.Y., Sept. 28, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fiscal 2018 fourth quarter and fiscal year ended June 30, 2018. Fourth Quarter Fiscal 2018 versu...
ACETO Announces Credit Agreement Amendment
ACETO Announces Credit Agreement Amendment Will File Form 12b-25 to Extend Submission of Form 10-K Until September 28, 2018 On September 28, 2018 Company will Report Fourth Quarter & Fiscal 2018 Financial Results and Hold Earnings Conference Call Board of Directors Declares a Dividend of $0.01 per Share PORT WASHINGTON, N.Y., Sept. 12, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that the Company h...
ACETO Corporation Schedules Fourth Quarter & Fiscal 2018 Financial Res...
ACETO Corporation Schedules Fourth Quarter & Fiscal 2018 Financial Results News Release and Conference Call PORT WASHINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter and full year of fiscal 2018 ended June 30, 2018 after the stock market close on Wednesday, September 12, 2018. Management will host a conference call to discu...
ACETO Subsidiary Acetris Health Receives Favorable Ruling Regarding Ce...
ACETO Subsidiary Acetris Health Receives Favorable Ruling Regarding Certain Government Contracts PORT WASHINGTON, N.Y., July 16, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that the United States Court of Federal Claims issued a decision in Acetris Health, LLC v. United States, invalidating the U.S. Department of Veterans Affairs interpretation of the Trade Agreements Clause, which had resulted i...
ACETO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swi...
NEW ORLEANS--(BUSINESS WIRE)-- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 25, 2018 to file lead plaintiff applications in a securities class action lawsuit against Aceto Corporation (NasdaqGS: ACET), if they purchased the Company’s shares between August 25, 2017 and April 18, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York. What You Ma...
The Klein Law Firm Reminds Investors of a Class Action Commenced on Be...
NEW YORK--(BUSINESS WIRE)-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Aceto Corporation (NASDAQ:ACET) who purchased shares between August 25, 2017 and April 18, 2018. The action, which was filed in the United States District Court for the Eastern District of New York, alleges that the Company violated federal securities laws. In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or ...
ACET EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors o...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of investors who purchased Aceto Corporation ("Aceto") (NASDAQ: ACET) securities between August 25, 2017 and April 18, 2018. Click here to learn about the case: http://www.wongesq.com/pslra-c/aceto-corporation?wire=2. There is no cost or obligation to you. According to the complaint, throughout the Class Period, the Compa...
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Co...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Aceto Corporation (NASDAQGS: ACET) between August 25, 2017 and April 18, 2018. You are hereby notified that Levi & Korsinsky has commenced the class action Mulligan v. Aceto Corporation (Case No. 9:18-cv-02425) in the USDC for the Eastern District of New York. To get more information go to: http://www.zlk.com/pslra-d/aceto-corporation?wire=2 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.